ID |
IPI |
Description |
Subcellular localization |
Protein abundance and peptides identification |
GroSize |
ProGroup |
PM |
Cyto |
Mito |
rER |
sER |
Nucl |
4411 |
IPI00740858.1 |
Cutaneous T-cell lymphoma-associated antigen 4 |
Cyto(G2) |
- |
- |
- |
1.14E-02 (ISHATEELETYR;DFPGPPHAPFAMR) |
- |
- |
1 |
IPI00740858.1
|
4412 |
IPI00740961.3 |
Similar to CG3173-PA isoform 1 |
Nucl(G1) |
- |
2.88E-03 (VLLNHFMLCIRELLSAHK;LAVAHPLLLLR) |
- |
- |
- |
2.33E-02 (LSPSAASDAVLSALLSIFSR;RDAAAALSSASALTGLTK;TFVDNIQTAFNTR;PVALALQQALGQELAR;FITLLADTSDSR) |
2 |
IPI00166215.4, IPI00740961.3
|
4413 |
IPI00741097.1 |
Glutathione S-transferase theta-1 |
Cyto(SP,GO) |
- |
1.20E+00 (AVYIFAK;AFLTGPHISLADLVAITELMHPVGAGCQVFEGR;AFLTGPHISLADLVAITELMHPVGAGCQVFEGRPK;AKDFPPADPTIK;GQHLSDAFAQVNPLK;GQHLSDAFAQVNPLKK;VPDYWYPQDLQAR;YKVPDYWYPQDLQAR;QRVEAAVGEDLFQEAHEVILK;VDEYLAWQHTTLR; |
- |
- |
- |
- |
1 |
IPI00741097.1
|
4414 |
IPI00741181.1 |
Similar to Heat shock protein HSP 90-beta |
Cyto(G1) |
- |
4.59E-01 (KHLEINPNHPIVETLR;HLEINPNHPIVETLR) |
- |
- |
- |
- |
1 |
IPI00741181.1
|
4415 |
IPI00741527.1 |
Isoform 3 of Usherin precursor |
PM(G2); Cyto(GO) |
- |
- |
- |
5.76E-03 (APTFHVISSTQAVVNISAPGK;LYQVALTNREILEVFSGDLLR;GINSTTIHLR) |
- |
- |
2 |
IPI00410150.1, IPI00741527.1
|
4416 |
IPI00741536.2 |
Similar to protein tyrosine phosphatase, receptor type, Q isoform 1 precursor |
Cyto(G2) |
- |
- |
5.34E-03 (PNGIIIAYEVLYKNIDTLYMK;NVQVLVTETGAQHDGNVTK) |
- |
- |
- |
1 |
IPI00741536.2
|
4417 |
IPI00741560.1 |
Novel protein |
Nucl(G2) |
- |
1.08E-02 (CFGAWQQFVQRGSR;DSLNPEQGLPPAHPLGSGDSCSPWSQDGR) |
- |
- |
- |
- |
1 |
IPI00741560.1
|
4418 |
IPI00741973.1 |
Similar to peptidylprolyl isomerase A isoform 1 |
Cyto(G2) |
- |
- |
- |
- |
8.03E-02 (EGMDIVEAMER;VKEGMDIVEAMER) |
- |
1 |
IPI00741973.1
|
4419 |
IPI00742682.1 |
Nuclear pore complex-associated protein TPR |
Nucl(SP,GO,HPA) |
- |
5.10E-03 (GNHVIRDEEVSSADISSSSEVISQHLVSYR;SNASLTNNQNLIQSLK;QSSVLERDNR) |
4.50E-03 (LSNLYKSAADDSEAKSNELTR;VRKLELDILPLQEANAELSEK) |
- |
- |
2.32E+00 (AIQDHLLEVEQSK;EGVQGPLNVSLSEEGK;ELENANDLLSATK;ELLHSQNTWLNTELK;FKVESEQQYFEIEK;FKVESEQQYFEIEKR;FLADQQSEIDGLK;GQPSNKEDVDDLVSQLR;ISTQLDFASK;LESALTELEQLR;LESALTELEQLRK;LQEQVTDLR;LTELYNAYVETQDQLLLE |
2 |
IPI00022970.4, IPI00742682.1
|
4420 |
IPI00742696.2 |
vitamin D-binding protein precursor |
ER(G1); Cyto(GO) |
8.37E-02 (VPTADLEDVLPLAEDITNILSK;YTFELSR) |
4.29E-01 (EDFTSLSLVLYSR;HLSLLTTLSNR;HQPQEFPTYVEPTNDEICEAFR;LCDNLSTKNSKFEDCCQEK;SLGECCDVEDSTTCFNAK;VPTADLEDVLPLAEDITNILSK;KFPSGTFEQVSQLVK;RTHLPEVFLSK;FPSGTFEQVSQLVK;LPDATPTELAK) |
- |
1.05E+00 (EDFTSLSLVLYSR;EVVSLTEACCAEGADPDCYDTR;HLSLLTTLSNR;KFPSGTFEQVSQLVK;LPDATPTELAK;RTHLPEVFLSK;VMDKYTFELSR;VPTADLEDVLPLAEDITNILSK;FPSGTFEQVSQLVK;EYANQFMWEYSTNYGQAPLSLLVSYTK;AKLPDATPTELAK;ELSSFIDK) |
1.06E+00 (HLSLLTTLSNR;KFPSGTFEQVSQLVK;LPDATPTELAK;RTHLPEVFLSK;VPTADLEDVLPLAEDITNILSK;YTFELSRRTHLPEVFLSK;YTFELSR;ELSSFIDK;EDFTSLSLVLYSR) |
- |
1 |
IPI00742696.2
|
4421 |
IPI00742703.1 |
PLCG1 variant protein (Fragment) |
Nucl(G2); Cyto(GO); PM(GO) |
- |
- |
- |
- |
9.62E-03 (LTEGKIMER;EDELTFTKSAIIQNVEK) |
- |
2 |
IPI00742703.1, IPI00745182.1
|
4422 |
IPI00742726.1 |
Testicular soluble adenylyl cyclase |
Cyto(G2,SP); PM(SP) |
- |
- |
- |
1.54E-02 (PFMDYFDGVLMFVDISGKSFTAMTEK;KMAMSHGFKTEEK;LTEKLNMVTLHSDK) |
- |
- |
1 |
IPI00742726.1
|
4423 |
IPI00742743.1 |
Isoform 2 of Tumor suppressor p53-binding protein 1 |
Nucl(SP,GO,HPA); Cyto(GO) |
- |
- |
- |
8.13E-03 (ENPVLDVVSNPEQTAGEERGDGNSGFNEHLK;QDKPMDTSVLSEEGGEPFQK) |
- |
3.11E-02 (SGTAETEPVEQDSSQPSLPLVR;ETAVPGPLGIEDISPNLSPDDK;VITDVYYVDGTEVER;VPETVSAATQTIK;ENPVLDVVSNPEQTAGEER;SNVSSPATPTASSSSSTTPTR) |
3 |
IPI00029778.3, IPI00657708.1, IPI00742743.1
|
4424 |
IPI00742748.1 |
Isoform 2 of Obscurin |
Cyto(G2,SP,GO) |
7.25E-03 (GWRLEILEPLK;SAQPHHAGEVTFACRDAVASAR;LSRASGQEAR;EGVELHAGPK;DLGDPSMDK) |
2.17E-03 (DGAPLESSSR;EVQAEAGASATLSCEVAQAQTEVTWYK;CLAENSMGVSSTK;LSFHLHVAEPKAVFAKEQPASR;EAMRAEGAPASPPSTGTR;YSCSFGDQTTSATLTVTALPAQFIGK) |
3.28E-03 (EHEDIILTATLATPSAATVTWLKDGVEIRR;CELSRAGTPVHWLK;DGGTYEVR;DFIKATLQRAPQAR) |
- |
2.82E-03 (DFIKATLQRAPQAR;VTFLAGDMVTSAFLTVRGWR;CELQIRGLVAEDAGEYLCMCGK) |
- |
2 |
IPI00742748.1, IPI00288940.5
|
4425 |
IPI00742825.1 |
32 kDa protein |
Cyto(G2,SP,GO,HPA) |
- |
- |
- |
- |
2.92E-02 (IQLVEEELDR;RIQLVEEELDR;MEIQEIQLK;SIDDLEVIKWLMPKK) |
- |
1 |
IPI00742825.1
|
4426 |
IPI00742835.1 |
Conserved hypothetical protein |
ER(G2) |
- |
6.25E-02 (DANWPGIRIPHLSK;ARALGLPPPVPCSTPSVHKALPSWDLFR) |
- |
- |
- |
- |
1 |
IPI00742835.1
|
4427 |
IPI00742863.1 |
74 kDa protein |
Nucl(G2) |
- |
4.30E-02 (TVNLTDFSNKWDSTNPFPK;MALSLEEFVHSLDLR) |
- |
- |
- |
- |
2 |
IPI00166184.2, IPI00742863.1
|
4428 |
IPI00742905.1 |
146 kDa protein |
Cyto(G1); Nucl(G1) |
- |
1.28E-01 (AIEPPPLDAVIEAEHTLR;GMTLVTPLQLLLFASK;LAAQSCALSLVR;LQISHEAAACITGLR;NELMYQLEQDHDLQAILQER;TTQVPQFILDDFIQNDR;AAMEALVVEVTK;ELDALDANDELTPLGR;FSDHVALLSVFQAWDDAR;GISHVIVDEIHER;GSGGFQRGGGR;TPLHEIALSIK |
- |
- |
- |
1.10E+00 (AENNSEVGASGYGVPGPTWDR;AIEPPPLDAVIEAEHTLR;ETPFELIEALLK;GMTLVTPLQLLLFASK;KFESEILEAISQNSVVIIR;KVQSDGQIVLVDDWIK;LAAQSCALSLVR;LQISHEAAACITGLR;NELMYQLEQDHDLQAILQER;QPAIISQLDPVNER;TTQVPQFILDDFIQNDR |
2 |
IPI00215638.6, IPI00742905.1
|
4429 |
IPI00742944.2 |
Formin-2 |
Nucl(G2) |
- |
- |
- |
9.97E-03 (GGGGGGGGGESGKK;LEDAETESQSAVSETPQKRSDAVQK) |
- |
- |
1 |
IPI00742944.2
|
4430 |
IPI00742984.1 |
Calpain-5 |
PM(G1) |
1.10E-01 (DTFFQNPQYIFEVK;VLFEDPLFPATDDSLYYK;DSPTGANSYVIIK;LSQPITVQVWNHR) |
- |
- |
- |
- |
- |
2 |
IPI00643994.1, IPI00742984.1
|
4431 |
IPI00743072.1 |
Interferon-inducible protein AIM2 |
Nucl(G2,SP,GO,HPA); Mito(GO,HPA) |
- |
- |
- |
- |
2.90E-02 (VFNTLLKDKFIPK;FIPKRIIIIAR) |
- |
3 |
IPI00024230.2, IPI00647481.1, IPI00743072.1
|
4432 |
IPI00743092.1 |
36 kDa protein |
ER(G1) |
1.93E-01 (DWSHYFK;LQLETEIEALK;LQLETEIEALKEELLFMK;QAKEYEALLNIK;DWSHYFKTIEDLR) |
- |
- |
5.48E-02 (LQLETEIEALKEELLFMK;DWSHYFKTIEDLR) |
2.23E-01 (LQLETEIEALKEELLFMK;QAKEYEALLNIK;DWSHYFKTIEDLR) |
- |
1 |
IPI00743092.1
|
4433 |
IPI00743104.1 |
131 kDa protein |
ER(G1); PM(GO) |
4.74E-01 (DLNLDGFNDIVIGAPLEDDHGGAVYIYHGSGK;KNEPLASYLGYTVNSATASSGDVLYIAGQPR;SKEDTIYEADLQYR;TIVHYSPNLVFSGIEAIQK;VIQDCEDENIQR;WVLIGSPLVGQPK;YSSTEEVLVAAK;ELAIQISK;VGYPFLR;FSIAILGSYNR) |
2.70E-02 (DLNLDGFNDIVIGAPLEDDHGGAVYIYHGSGK;VIQDCEDENIQR;VGYPFLR;RGEMVTFK;SYFSSLNLTIRGELR) |
- |
1.27E-02 (SKEDTIYEADLQYR;YSSTEEVLVAAK) |
4.84E-01 (DLNLDGFNDIVIGAPLEDDHGGAVYIYHGSGK;FEYQMSLEPIK;FSIAILGSYNR;KNEPLASYLGYTVNSATASSGDVLYIAGQPR;QTMTALGIDTAR;SKEDTIYEADLQYR;TIVHYSPNLVFSGIEAIQK;VMVIVTDGESHDNHR;VTMNFEPNKVNIQK;WVLIGSPLVGQPK;YSSTEEVL |
1.46E-01 (DLNLDGFNDIVIGAPLEDDHGGAVYIYHGSGK;KNEPLASYLGYTVNSATASSGDVLYIAGQPR;SKEDTIYEADLQYR;YSSTEEVLVAAK;TIVHYSPNLVFSGIEAIQK;VIQDCEDENIQR;DSNTDILLVGAPMYMGTEKEEQGKVYVYALNQTR) |
2 |
IPI00472202.2, IPI00743104.1
|
4434 |
IPI00743178.2 |
Hypothetical protein DKFZp686O0759 |
Nucl(G1,GO,HPA) |
- |
- |
- |
- |
- |
6.43E-01 (LLLGYSDIEIPSVVSVQSVQK;IHSINLHNFSNSVLETLNEQR;CVLAAGSPFFQDK;HVALHSASNGTPPAGTPPGAR;NESEECTEDTDQAEGTESEPK;SFYSGAVVSHHETALGLPR;VSQSEALQILTAASILQIK;IQTLVGNIHIK;PVRIQTLVGNIHIK) |
1 |
IPI00743178.2
|
4435 |
IPI00743189.1 |
37 kDa protein |
Nucl(G1) |
- |
- |
- |
- |
- |
6.04E-02 (LRILKAMNLDK;FTSLNESITTK) |
1 |
IPI00743189.1
|
4436 |
IPI00743256.1 |
Death receptor interacting protein |
Cyto(G2) |
1.26E-02 (DTRLGENIIPYVADGAK;EPTLEMFLSR) |
- |
- |
1.91E-02 (FPELYPFLLK;EPTLEMFLSR) |
3.68E-02 (EPTLEMFLSR;FPELYPFLLK) |
- |
1 |
IPI00743256.1
|
4437 |
IPI00743284.1 |
141 kDa protein |
Cyto(SP,GO,HPA) |
3.43E-02 (EKLNEEHFRGQEFK;VLNGTVEEEASDPYQGTIVLATVK;IVGDLFGAGK) |
1.10E-02 (AALFALQNLFEEK;IPLLIGGATTSK;VPLCIDSSNFAVIEAGLK) |
- |
- |
1.11E-02 (VYDDAHNMLNTLISQK;DPEATEKLLR) |
- |
1 |
IPI00743284.1
|
4438 |
IPI00743293.1 |
RTN3-A1 |
ER(SP,GO,HPA) |
- |
- |
- |
- |
9.28E-02 (TQIDHYVGIAR;YKTQIDHYVGIAR) |
- |
6 |
IPI00028946.1, IPI00177423.3, IPI00398795.3, IPI00412154.3, IPI00555783.2, IPI00743293.1
|
4439 |
IPI00743314.1 |
General vesicular transport factor p115 |
Cyto(SP) |
- |
9.87E-01 (CQNEQLQTAVTQQVSQIQQHK;DKLELEITDSK;DKLELEITDSKK;DLGHPVEEEDELESGDQEDEDDESEDPGKDLDHI;DNQHQGSYSEGAQMNGIQPEEIGR;EQDDLLVLLADQDQK;EQLDSSNSTIAILQTEK;IVAFENAFER;KEQDDLLVLLADQDQK;LKDLGHPVEEEDELESGDQED |
- |
- |
- |
- |
1 |
IPI00743314.1
|
4440 |
IPI00743335.1 |
MYO1C variant protein |
PM(G1); Cyto(SP,GO); Nucl(SP) |
2.52E-01 (DGTIDFTPGSELLITK;MSLLQLVEILQSK;ENLIYTYIGPVLVSVNPYR;GEELLSPLNLEQAAYAR;GVSFYEVPPHLFAVADTVYR;LLQSNPVLEAFGNAK;NFHIFYQLLEGGEEETLR) |
- |
- |
- |
3.80E-02 (GAPVGGHILSYLLEK;GEELLSPLNLEQAAYAR;VGVQDFVLLENFTSEAAFIENLR;VNSININQGSITFAGGPGR;VLQALGSEPIQYAVPVVK;DGTIDFTPGSELLITK) |
1.29E-02 (KDNYPQSVPR;QQLQQKAVASEIFK) |
2 |
IPI00010418.4, IPI00743335.1
|